Foghorn Therapeutics Inc. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Foghorn Therapeutics Inc. (FHTX) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$68.80 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-18.
Discontinued › Income Statement
us-gaap:ProfitLoss · last filed 2021-03-18
- Foghorn Therapeutics Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2020-12-31 was -$20.76M.
- Foghorn Therapeutics Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2019-12-31 was -$15.29M.
- Foghorn Therapeutics Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2020 was -$68.80M.
- Foghorn Therapeutics Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2019 was -$51.13M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|
| 2020-12-31 | -$20.76M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$68.80M 10-K · filed 2021-03-18 | |
| 2020-09-30 | -$48.04M 10-Q · filed 2020-12-04 | ||
| 2019-12-31 | -$15.29M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$51.13M 10-K · filed 2021-03-18 | |
| 2019-09-30 | -$35.84M 10-Q · filed 2020-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |